2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Robert S. Sheldon, Blair P. Grubb II, Brian Olshansky, Win-Kuang Shen, Hugh Calkins, Michele Brignole, Satish R. Raj, Andrew D. Krahn, Carlos A. Morillo, Julian M. Stewart, Richard Sutton, Paola Sandroni, Karen J. Friday, Denise Tessariol Hachul, Mitchell I. Cohen, Dennis H. Lau, Kenneth A. Mayuga, Jeffrey P. Moak, Roopinder K. Sandhu, Khalil Kanjwal

[1]  D. Packer,et al.  Is Sinus Node Modification Appropriate for Inappropriate Sinus Tachycardia with Features of Postural Orthostatic Tachycardia Syndrome? , 2001, Pacing and clinical electrophysiology : PACE.

[2]  E. Benarroch.  Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. , 2012, Mayo Clinic proceedings.

[3]  R. García-Civera,et al.  Mechanism of Syncope in Patients With Isolated Syncope and in Patients With Tilt-Positive Syncope , 2001, Circulation.

[4]  P. Tchou,et al.  Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome. , 2002, Journal of the American College of Cardiology.

[5]  G. Jacob,et al.  Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. , 1997, Circulation.

[6]  J. Blanc,et al.  Pacemaker Therapy in Patients With Neurally Mediated Syncope and Documented Asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3) A Randomized Trial , 2012, Circulation.

[7]  R. Sheldon,et al.  Recent History of Vasovagal Syncope in a Young, Referral‐Based Population Is a Stronger Predictor of Recurrent Syncope Than Lifetime Syncope Burden , 2010, Journal of cardiovascular electrophysiology.

[8]  R. García-Civera,et al.  Mechanism of Syncope in Patients With Isolated Syncope and in Patients With Tilt-Positive Syncope , 2002 .

[9]  R Yee,et al.  Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing. , 1998, The American journal of cardiology.

[10]  P. Low,et al.  Postural tachycardia in children and adolescents: what is abnormal? , 2012, The Journal of pediatrics.

[11]  W. Shen,et al.  Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. , 2013, Translational research : the journal of laboratory and clinical medicine.

[12]  V. Novak,et al.  Mechanisms of blood pressure alterations in response to the Valsalva maneuver in postural tachycardia syndrome , 2000, Clinical Autonomic Research.

[13]  S. Connolly,et al.  Historical criteria that distinguish syncope from seizures. , 2002, Journal of the American College of Cardiology.

[14]  H. Huikuri,et al.  Prevalence, characteristics and natural course of inappropriate sinus tachycardia. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  M. Brignole,et al.  A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). , 2004, European heart journal.

[16]  G. Glick,et al.  Hemodynamic changes during spontaneous vasovagal reactions. , 1963, The American journal of medicine.

[17]  P. Bossuyt,et al.  Diagnosing vasovagal syncope based on quantitative history-taking: validation of the Calgary Syncope Symptom Score. , 2009, European heart journal.

[18]  Raffaello Furlan,et al.  The Elusive Pathophysiology of Neurally Mediated Syncope , 2000, Circulation.

[19]  A. Waldo.  Reproducibility of Electrocardiographic Findings in Patients With Suspected Reflex Neurally-Mediated Syncope , 2009 .

[20]  B. Westerhof,et al.  Sublingual nitroglycerin used in routine tilt testing provokes a cardiac output-mediated vasovagal response. , 2004, Journal of the American College of Cardiology.

[21]  T. Wein,et al.  Orthostatic intolerance in the chronic fatigue syndrome. , 1999, Journal of the autonomic nervous system.

[22]  S. Raj.  Postural Tachycardia Syndrome (POTS) , 2013, Circulation.

[23]  W. Dupont,et al.  Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics. , 2013, Clinical science.

[24]  L. Montgomery,et al.  Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.

[25]  P. Low,et al.  Idiopathic postural orthostatic tachycardia syndrome , 1993, Neurology.

[26]  M. Brignole,et al.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. , 2000, Circulation.

[27]  J. Blanc.  Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation? , 2013, Progress in cardiovascular diseases.

[28]  Robert S Sheldon,et al.  Vasovagal syncope in medical students and their first-degree relatives. , 2006, European heart journal.

[29]  C. Morillo,et al.  Impaired Baroreflex Gain in Patients with Inappropriate Sinus Tachycardia , 2005, Journal of cardiovascular electrophysiology.

[30]  M. Brignole,et al.  Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. , 2002, Journal of the American College of Cardiology.

[31]  S. Raj,et al.  Rationale for the prevention of syncope trial IV: assessment of midodrine , 2012, Clinical Autonomic Research.

[32]  J. Deharo,et al.  Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. , 2013, Journal of the American College of Cardiology.

[33]  A. Barsotti,et al.  Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. , 1999, Journal of the American College of Cardiology.

[34]  R Yee,et al.  Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. , 1999, Circulation.

[35]  C. Morillo,et al.  Age-Dependent Effect of &bgr;-Blockers in Preventing Vasovagal Syncope , 2012, Circulation. Arrhythmia and electrophysiology.

[36]  A. Ertl,et al.  The neuropathic postural tachycardia syndrome. , 2000, The New England journal of medicine.

[37]  T. Rummans,et al.  Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[38]  S. Raj,et al.  Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome , 2005, Circulation.

[39]  S. Connolly,et al.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. , 1999, Journal of the American College of Cardiology.

[40]  P. Chiale,et al.  Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. , 2006, Heart rhythm.

[41]  M. Santini,et al.  Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope: A Multicenter, Randomized, Controlled Trial , 2001, Circulation.

[42]  R. Furlan,et al.  Incidence, etiology and predictors of adverse outcomes in 43,315 patients presenting to the Emergency Department with syncope: an international meta-analysis. , 2013, International journal of cardiology.

[43]  K. E. Lucas,et al.  Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. , 2001, JAMA.

[44]  M. Camilleri,et al.  Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. , 1994, Journal of the autonomic nervous system.

[45]  V. Novak,et al.  Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome , 2000, Clinical Autonomic Research.

[46]  J. Weinberg,et al.  Ehlers–Danlos Syndrome and Postural Tachycardia Syndrome: A relationship study , 2014, Journal of the Neurological Sciences.

[47]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[48]  B. Westerhof,et al.  Steep fall in cardiac output is main determinant of hypotension during drug-free and nitroglycerine-induced orthostatic vasovagal syncope. , 2008, Heart rhythm.

[49]  R. Sutton.  Treatment of Reflex Syncope , 2013 .

[50]  E. Benarroch,et al.  Deconditioning in patients with orthostatic intolerance , 2012, Neurology.

[51]  G. Cayla,et al.  A Case of Cardiomyopathy Induced by Inappropriate Sinus Tachycardia and Cured by Ivabradine , 2009, Pacing and clinical electrophysiology : PACE.

[52]  M. Brignole,et al.  Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial). , 2006, Journal of the American College of Cardiology.

[53]  J. Reitsma,et al.  Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[54]  J. G. Dijk,et al.  ESC Guidelines for the Diagnosis and Management of Syncope (Version 2009) , 2009 .

[55]  R. Sheldon,et al.  Evidence-based treatment for vasovagal syncope. , 2008, Heart rhythm.

[56]  M. Brignole,et al.  Diagnostic value of history in patients with syncope with or without heart disease. , 2001, Journal of the American College of Cardiology.

[57]  R Furlan,et al.  Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. , 1997, The Journal of clinical investigation.

[58]  L. Montgomery,et al.  Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow. , 2004, American journal of physiology. Heart and circulatory physiology.

[59]  C. Morillo,et al.  Mechanism of ‘Inappropriate’ Sinus Tachycardia: Role of Sympathovagal Balance , 1994, Circulation.

[60]  M. Esler,et al.  Persistence of muscle sympathetic nerve activity during vasovagal syncope. , 2010, European heart journal.

[61]  M. Brignole,et al.  New concepts in the assessment of syncope. , 2012, Journal of the American College of Cardiology.

[62]  M. Seeck,et al.  Orthostatic intolerance and syncope associated with Chiari type I malformation , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[63]  S. Raj,et al.  The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome , 2007, Neurology.

[64]  W. Shen,et al.  Postural orthostatic tachycardia syndrome: the Mayo clinic experience. , 2007, Mayo Clinic proceedings.

[65]  J. Stewart,et al.  What is brain fog? An evaluation of the symptom in postural tachycardia syndrome , 2013, Clinical Autonomic Research.

[66]  B. Levine,et al.  Exercise Training Versus Propranolol in the Treatment of the Postural Orthostatic Tachycardia Syndrome , 2011, Hypertension.

[67]  D. Ewing,et al.  Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. , 1974, Clinical science and molecular medicine.

[68]  B. Sarubbi,et al.  A Pediatric Case of Cardiomyopathy Induced by Inappropriate Sinus Tachycardia: Efficacy of Ivabradine , 2011, Pediatric Cardiology.

[69]  A. Skanes,et al.  Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[70]  M. Salim,et al.  Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. , 2005, Journal of the American College of Cardiology.

[71]  J. Cigrang,et al.  Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. , 2003, Circulation.

[72]  R. Page,et al.  Serotonin Reuptake Inhibitor (Paxil) Does Not Prevent the Vasovagal Reaction Associated With Carotid Sinus Massage and/or Lower Body Negative Pressure in Healthy Volunteers , 2002, Circulation.

[73]  L. Montgomery,et al.  Regional blood volume and peripheral blood flow in postural tachycardia syndrome. , 2004, American journal of physiology. Heart and circulatory physiology.

[74]  Allan C Skanes,et al.  Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. , 2003, Journal of the American College of Cardiology.

[75]  S. Connolly,et al.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. , 2003, JAMA.

[76]  B. Gersh,et al.  Prevalence and clinical outcomes of patients with multiple potential causes of syncope. , 2003, Mayo Clinic proceedings.

[77]  B. Grubb,et al.  Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single‐Center Experience , 2011, Pacing and clinical electrophysiology : PACE.

[78]  J. Norrie,et al.  Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures , 1999, Heart.

[79]  J. Deharo,et al.  Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. , 2011, Journal of the American College of Cardiology.

[80]  W. Dupont,et al.  Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More , 2009, Circulation.

[81]  P. Haber,et al.  Endurance Exercise Training in Orthostatic Intolerance: A Randomized, Controlled Trial , 2005, Hypertension.

[82]  J. Wranicz,et al.  Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia , 2013, Journal of cardiovascular pharmacology and therapeutics.

[83]  Richard Sutton,et al.  Key challenges in the current management of syncope , 2012, Nature Reviews Cardiology.

[84]  Mark Linzer,et al.  Lifetime Cumulative Incidence of Syncope in the General Population: A Study of 549 Dutch Subjects Aged 35–60 Years , 2006, Journal of cardiovascular electrophysiology.

[85]  W. Shen,et al.  Inappropriate Sinus Tachycardia, Postural Orthostatic Tachycardia Syndrome, and Overlapping Syndromes , 2005, Pacing and clinical electrophysiology : PACE.

[86]  S. Connolly,et al.  Diagnostic criteria for vasovagal syncope based on a quantitative history. , 2006, European heart journal.

[87]  M. Brignole,et al.  Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease. , 2004, European heart journal.

[88]  J. Deharo,et al.  Benefit of Pacemaker Therapy in Patients With Presumed Neurally Mediated Syncope and Documented Asystole Is Greater When Tilt Test Is Negative: An Analysis From the Third International Study on Syncope of Uncertain Etiology (ISSUE-3) , 2014, Circulation. Arrhythmia and electrophysiology.

[89]  J. Newton,et al.  Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome , 2013, Journal of internal medicine.

[90]  J. Reitsma,et al.  High Diagnostic Yield and Accuracy of History, Physical Examination, and ECG in Patients with Transient Loss of Consciousness in FAST: The Fainting Assessment Study , 2007, Journal of cardiovascular electrophysiology.

[91]  J. Tyberg,et al.  Abnormal reflex venous function in patients with neuromediated syncope. , 1996, Journal of the American College of Cardiology.

[92]  Victor A. Convertino,et al.  Association between vasovagal hypotension and low sympathetic neural activity during presyncope , 2002, Clinical Autonomic Research.

[93]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[94]  Hongliang Li,et al.  Autoimmune Basis for Postural Tachycardia Syndrome , 2014, Journal of the American Heart Association.

[95]  M. Frenneaux,et al.  Failure of reflex venoconstriction during exercise in patients with vasovagal syncope. , 1996, Circulation.

[96]  B. Levine,et al.  Pathophysiology of neurally mediated syncope: Role of cardiac output and total peripheral resistance , 2014, Autonomic Neuroscience.

[97]  R. García-Civera,et al.  Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. , 2006, European heart journal.

[98]  S. Raj,et al.  Hyperadrenergic Postural Tachycardia Syndrome in Mast Cell Activation Disorders , 2005, Hypertension.

[99]  Chao-shu Tang,et al.  Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[100]  M. Santini,et al.  Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. , 2002, European heart journal.

[101]  D. Kremastinos,et al.  Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[102]  H. Huikuri,et al.  Heart rate variability in inappropriate sinus tachycardia. , 1998, The American journal of cardiology.

[103]  R. Sheldon.  How to Differentiate Syncope from Seizure. , 2015, Cardiology clinics.

[104]  S. Connolly,et al.  Age of First Faint in Patients with Vasovagal Syncope , 2006, Journal of cardiovascular electrophysiology.

[105]  A. Hersi,et al.  Syncope and Structural Heart Disease: Historical Criteria for Vasovagal Syncope and Ventricular Tachycardia , 2010, Journal of cardiovascular electrophysiology.

[106]  N. Freemantle,et al.  The clinical impact of implantable loop recorders in patients with syncope. , 2006, European heart journal.

[107]  R. Cappato,et al.  Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. , 2012, Journal of the American College of Cardiology.

[108]  K. Lurie,et al.  Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. , 2001, The American journal of cardiology.

[109]  Chao-shu Tang,et al.  Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[110]  A. Pedrote,et al.  Long-term outcome of patients with vasovagal syncope. , 2004, American heart journal.

[111]  J. Segovia,et al.  Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. , 2001, Journal of the American College of Cardiology.

[112]  S. Raj,et al.  Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome , 2005, Circulation.

[113]  M. Esler,et al.  Recurrent Postural Vasovagal Syncope: Sympathetic Nervous System Phenotypes , 2011, Circulation: Arrhythmia and Electrophysiology.

[114]  J. McArthur,et al.  Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies , 2004, Neurology.

[115]  A. Raviele,et al.  A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE) , 2005 .

[116]  C. Frampton,et al.  Decrease in cardiac output and muscle sympathetic activity during vasovagal syncope. , 2002, American journal of physiology. Heart and circulatory physiology.

[117]  M. Joyner,et al.  Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety. , 2007, Journal of applied physiology.

[118]  J. Blanc,et al.  Guidelines for the diagnosis and management of syncope (version 2009). , 2009, European heart journal.

[119]  A. Natale,et al.  Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. , 1995, Circulation.

[120]  Lily Wang,et al.  Distal sudomotor findings in postural tachycardia syndrome , 2010, Clinical Autonomic Research.

[121]  S. Seslar.  Cardiac Origins of Postural Orthostatic Tachycardia Syndrome , 2010 .

[122]  S. Bruehl,et al.  Effect of Modafinil on Acute Pain: A Randomized Double‐Blind Crossover Study , 2004, Journal of clinical pharmacology.

[123]  Mark Linzer,et al.  Management of Vasovagal Syncope: Controlling or Aborting Faints by Leg Crossing and Muscle Tensing , 2002, Circulation.

[124]  M. Brignole,et al.  Management of syncope referred urgently to general hospitals with and without syncope units. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[125]  C. G. Blomqvist,et al.  Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia. , 1983, Chest.

[126]  A. Muir,et al.  Lack of variation in venous tone potentiates vasovagal syncope. , 1992, British heart journal.

[127]  Frank Beckers,et al.  Impact of age on the vasovagal response provoked by sublingual nitroglycerine in routine tilt testing. , 2007, Clinical science.

[128]  A. Krahn,et al.  The etiology of syncope in patients with negative tilt table and electrophysiological testing. , 1995, Circulation.

[129]  P. Tchou,et al.  Usefulness of Midodrine in Patients with Severely Symptomatic Neurocardiogenic Syncope: A Randomized Control Study , 2001, Journal of cardiovascular electrophysiology.

[130]  Cheng Wang,et al.  [Efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope]. , 2009, Zhonghua yi xue za zhi.

[131]  N. Marchionni,et al.  Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls , 2014, Aging Clinical and Experimental Research.

[132]  D. Robertson,et al.  The epidemic of orthostatic tachycardia and orthostatic intolerance. , 1999, The American journal of the medical sciences.

[133]  Jens Jordan,et al.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome , 2011, Clinical Autonomic Research.

[134]  C. Mussi,et al.  A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. , 2005, European heart journal.

[135]  J. Newton,et al.  Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[136]  R. Sheldon,et al.  Electroencephalographic findings during presyncope and syncope induced by tilt table testing. , 1998, The Canadian journal of cardiology.

[137]  G. Mairesse,et al.  Treatment of Unexplained Syncope: A Multicenter, Randomized Trial of Cardiac Pacing Guided by Adenosine 5′-Triphosphate Testing , 2012, Circulation.

[138]  D L Eckberg,et al.  Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. , 1997, Circulation.

[139]  P. Sandroni,et al.  Blood pressure recovery from Valsalva maneuver in patients with autonomic failure , 2005, Neurology.

[140]  C. Morillo,et al.  Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[141]  M. Brignole,et al.  Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score , 2008, Heart.

[142]  R. Kenny,et al.  Midodrine: a role in the management of neurocardiogenic syncope , 1998, Heart.

[143]  S. Sonoda,et al.  Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome. , 2000, Journal of cardiovascular pharmacology.

[144]  M. Zimmerman,et al.  Are treatments for vasovagal syncope effective? A meta-analysis. , 2013, International journal of cardiology.

[145]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[146]  A. Skanes,et al.  Predicting the cause of syncope from clinical history in patients undergoing prolonged monitoring. , 2009, Heart rhythm.

[147]  D. Robertson,et al.  Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth? , 2001, The American journal of medicine.